DK2657234T3 - Optisk aktivt diazabicyclooctanderivat og fremgangsmåde til fremstilling heraf - Google Patents
Optisk aktivt diazabicyclooctanderivat og fremgangsmåde til fremstilling heraf Download PDFInfo
- Publication number
- DK2657234T3 DK2657234T3 DK11850585.8T DK11850585T DK2657234T3 DK 2657234 T3 DK2657234 T3 DK 2657234T3 DK 11850585 T DK11850585 T DK 11850585T DK 2657234 T3 DK2657234 T3 DK 2657234T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- optically active
- diazabicyclooctane derivative
- active diazabicyclooctane
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010073093 | 2010-12-22 | ||
PCT/JP2011/065001 WO2012086241A1 (ja) | 2010-12-22 | 2011-06-30 | 光学活性なジアザビシクロオクタン誘導体およびその製造法 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2657234T3 true DK2657234T3 (da) | 2017-02-20 |
Family
ID=46313528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11850585.8T DK2657234T3 (da) | 2010-12-22 | 2011-06-30 | Optisk aktivt diazabicyclooctanderivat og fremgangsmåde til fremstilling heraf |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2657234B1 (da) |
JP (3) | JP5903386B2 (da) |
KR (1) | KR101836554B1 (da) |
CN (2) | CN103328476B (da) |
AR (1) | AR116907A2 (da) |
AU (2) | AU2011346224B2 (da) |
CA (1) | CA2822758C (da) |
DK (1) | DK2657234T3 (da) |
ES (1) | ES2622004T3 (da) |
HK (1) | HK1210153A1 (da) |
HU (1) | HUE032491T2 (da) |
IL (5) | IL227087A0 (da) |
PL (1) | PL2657234T3 (da) |
RU (1) | RU2591701C2 (da) |
SG (2) | SG10201510576WA (da) |
SI (1) | SI2657234T1 (da) |
TW (1) | TWI599355B (da) |
WO (1) | WO2012086241A1 (da) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2622004T3 (es) * | 2010-12-22 | 2017-07-05 | Meiji Seika Pharma Co., Ltd. | Derivado de diazabiciclooctano ópticamente activo y método para preparar el mismo |
US8772490B2 (en) | 2010-12-22 | 2014-07-08 | Meiji Seika Pharma Co., Ltd. | Optically active diazabicyclooctane derivatives and process for preparing the same |
US8829191B2 (en) * | 2011-06-17 | 2014-09-09 | Melanie Simone Ronsheim | Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof |
US8969570B2 (en) | 2012-03-30 | 2015-03-03 | Cubist Pharmaceuticals, Inc. | Beta-lactamase inhibitors |
US8916709B2 (en) | 2012-03-30 | 2014-12-23 | Cubist Pharmaceuticals, Inc. | 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors |
US8962843B2 (en) | 2012-03-30 | 2015-02-24 | Cubist Pharmaceuticals, Inc. | 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
JP2015512419A (ja) | 2012-03-30 | 2015-04-27 | キュービスト ファーマシューティカルズ, インコーポレイテッド | イソオキザゾールβ−ラクタマーゼ阻害剤 |
WO2013180197A1 (ja) | 2012-05-30 | 2013-12-05 | Meiji Seikaファルマ株式会社 | 新規β-ラクタマーゼ阻害剤とその製造法 |
EP2915805A4 (en) * | 2012-11-01 | 2016-03-23 | Kaneka Corp | METHOD FOR PRODUCING AN OPTICALLY ACTIVE BICYCLIC UREA COMPOUND |
BR112015021332B1 (pt) * | 2013-03-08 | 2020-06-30 | Wockhardt Limited | sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação |
WO2014135931A1 (en) * | 2013-03-08 | 2014-09-12 | Wockhardt Limited | A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]- octane |
CN108191864A (zh) * | 2013-03-08 | 2018-06-22 | 沃克哈特有限公司 | 制备氧代磺酰氧基[(哌啶羰基)-肼基羰基]二氮杂-双环辛烷的方法 |
WO2014135930A1 (en) * | 2013-03-08 | 2014-09-12 | Wockhardt Limited | A process for sodium salt of (2s, 5r)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane |
WO2014135932A1 (en) | 2013-03-08 | 2014-09-12 | Wockhardt Limited | A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-pyrrolidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octane |
CA2904084C (en) * | 2013-03-08 | 2017-03-28 | Wockhardt Limited | A process for preparation of (2s, 5r)- sulfuric acid mono-{[(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester |
US9120795B2 (en) | 2013-03-14 | 2015-09-01 | Cubist Pharmaceuticals, Inc. | Crystalline form of a β-lactamase inhibitor |
DK3050883T3 (da) * | 2013-09-24 | 2020-05-25 | Meiji Seika Pharma Co Ltd | Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter |
US9120796B2 (en) | 2013-10-02 | 2015-09-01 | Cubist Pharmaceuticals, Inc. | B-lactamase inhibitor picoline salt |
ES2901198T3 (es) | 2013-10-08 | 2022-03-21 | Meiji Seika Pharma Co Ltd | Formas cristalinas de derivado de diazabiciclooctano y procedimiento de producción de las mismas |
WO2015114595A1 (en) * | 2014-02-03 | 2015-08-06 | Wockhardt Limited | A process for preparation of (2s, 5r)-1,6-diaza-bicyclo [3.2.1]octane-2-carbonitrile-7-oxo-6-(sulfooxy)-mono sodium salt |
EP3126363A1 (en) | 2014-03-29 | 2017-02-08 | Wockhardt Limited | A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate |
RU2732129C2 (ru) | 2014-12-05 | 2020-09-11 | Мейдзи Сейка Фарма Ко., Лтд. | Способ производства кристаллов производного диазабициклооктана и стабильного лиофилизированного препарата |
PT3334734T (pt) * | 2015-08-10 | 2020-04-06 | Sandoz Ag | Forma c de avibactam sódico |
CN107325096B (zh) * | 2016-04-29 | 2020-11-03 | 正大天晴药业集团股份有限公司 | 一种阿维巴坦单钠盐的结晶 |
CN106565712A (zh) * | 2016-09-30 | 2017-04-19 | 天津津泰生物医药技术有限公司 | 一种阿维巴坦钠中间体的制备方法 |
CN106699756B (zh) * | 2016-12-30 | 2019-10-29 | 淄博鑫泉医药技术服务有限公司 | β内酰胺酶抑制剂阿维巴坦的合成方法 |
CN106866668B (zh) * | 2017-01-23 | 2019-01-11 | 齐鲁天和惠世制药有限公司 | 一锅法制备阿维巴坦钠的方法 |
CN106831772B (zh) * | 2017-03-04 | 2019-12-17 | 丽珠医药集团股份有限公司 | 一种阿维巴坦中间体的合成方法 |
US10085999B1 (en) | 2017-05-10 | 2018-10-02 | Arixa Pharmaceuticals, Inc. | Beta-lactamase inhibitors and uses thereof |
WO2018234962A1 (en) * | 2017-06-20 | 2018-12-27 | Wockhardt Limited | PROCESS FOR O-SULFONATION OF 1,6-DIAZABICYCLO [3.2.1] OCTANE COMPOUNDS |
CN109400521B (zh) * | 2017-08-18 | 2020-05-08 | 新发药业有限公司 | 一种改进的5r-苄氧氨基哌啶-2s-甲酸酯、其草酸盐的制备方法 |
CN107417686B (zh) * | 2017-09-19 | 2020-04-28 | 北京化工大学 | 一种阿维巴坦钠的合成方法 |
MX2020004071A (es) | 2017-10-02 | 2020-07-28 | Arixa Pharmaceuticals Inc | Derivados de aztreonam y usos de los mismos. |
CN109678856B (zh) * | 2017-10-18 | 2020-09-25 | 新发药业有限公司 | 一种阿维巴坦中间体的制备方法 |
CN109678855B (zh) | 2017-10-18 | 2020-07-17 | 新发药业有限公司 | 一种阿维巴坦中间体的制备方法 |
TWI826399B (zh) | 2017-11-03 | 2023-12-21 | 瑞士商愛爾康公司 | 氮雜雙環和二氮呯衍生物 |
CN107907604B (zh) * | 2017-11-07 | 2021-01-22 | 中山奕安泰医药科技有限公司 | (2s,5r)-苯氧胺基哌啶-2-甲酸乙酯草酸盐的检测方法 |
CN107941969B (zh) * | 2017-11-07 | 2021-03-02 | 中山奕安泰医药科技有限公司 | (2s,5r)-苯氧胺基哌啶-2-甲酰胺的检测方法 |
CN107894471A (zh) * | 2017-11-07 | 2018-04-10 | 中山奕安泰医药科技有限公司 | 一种阿维巴坦钠中间体的检测方法 |
TW201925201A (zh) * | 2017-11-10 | 2019-07-01 | 日商鹽野義製藥股份有限公司 | 二氮雜二環辛烷衍生物 |
CN107941944B (zh) * | 2017-11-23 | 2020-09-15 | 中山奕安泰医药科技有限公司 | 一种(2s,5r)-苄氧胺基哌啶-2-甲酸乙酯草酸盐的检测方法 |
US11180501B2 (en) | 2017-12-01 | 2021-11-23 | Qilu Pharmaceutical Co., Ltd. | Crystal form of β-lactamase inhibitor and preparation method therefor |
CN109956941B (zh) | 2017-12-25 | 2020-08-04 | 新发药业有限公司 | 一种阿维巴坦的简便制备方法 |
CN109970625B (zh) * | 2017-12-28 | 2021-02-26 | 新发药业有限公司 | 一种5r-苄氧氨基哌啶-2s-甲酸或其衍生物的制备方法 |
US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
US11897844B2 (en) * | 2018-09-21 | 2024-02-13 | Api Corporation | Method for producing amino acid derivatives |
US11180500B2 (en) | 2018-10-01 | 2021-11-23 | Arixa Pharmaceuticals, Inc. | Derivatives of relebactam and uses thereof |
US11008321B2 (en) | 2019-03-12 | 2021-05-18 | Arixa Pharmaceuticals, Inc. | Crystalline form of an avibactam derivative |
WO2020219258A1 (en) | 2019-04-25 | 2020-10-29 | Arixa Pharmaceuticals, Inc. | Methods of synthesizing aztreonam derivatives |
CN111777607A (zh) * | 2020-07-21 | 2020-10-16 | 海南海灵化学制药有限公司 | 一种阿维巴坦纳的制备方法 |
CN116375706A (zh) * | 2023-02-22 | 2023-07-04 | 时森海(杭州)医药科技有限公司 | 阿维巴坦钠关键中间体及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0737194B1 (en) * | 1993-12-29 | 1999-03-03 | Pfizer Inc. | Diazabicyclic neurokinin antagonists |
FR2812635B1 (fr) * | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
FR2835186B1 (fr) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
FR2921060B1 (fr) * | 2007-09-14 | 2012-06-15 | Novexel | Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires |
PT2666774E (pt) * | 2008-01-18 | 2015-04-13 | Merck Sharp & Dohme | Inibidores de beta-lactamase |
FR2930553B1 (fr) | 2008-04-29 | 2010-05-21 | Novexel | Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases |
EP2921559A1 (en) * | 2008-06-19 | 2015-09-23 | Astra Zeneca Holding France | Use of (1r,2s,5r) 1,6-diazabicyclo [3.2.1]octane-2-carboxamide, 7-oxo-6-(sulfooxy)-, monosodium salt as a diagnostic reagent for detecting serine beta-lactamases |
US20120053350A1 (en) | 2009-04-30 | 2012-03-01 | Ian Mangion | Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids |
FR2951171A1 (fr) * | 2009-10-09 | 2011-04-15 | Novexel | Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation |
ES2622004T3 (es) * | 2010-12-22 | 2017-07-05 | Meiji Seika Pharma Co., Ltd. | Derivado de diazabiciclooctano ópticamente activo y método para preparar el mismo |
-
2011
- 2011-06-30 ES ES11850585.8T patent/ES2622004T3/es active Active
- 2011-06-30 CA CA2822758A patent/CA2822758C/en active Active
- 2011-06-30 TW TW100123062A patent/TWI599355B/zh active
- 2011-06-30 CN CN201180061822.5A patent/CN103328476B/zh active Active
- 2011-06-30 HU HUE11850585A patent/HUE032491T2/en unknown
- 2011-06-30 SI SI201131101A patent/SI2657234T1/sl unknown
- 2011-06-30 AU AU2011346224A patent/AU2011346224B2/en not_active Ceased
- 2011-06-30 CN CN201510212878.6A patent/CN104892490B/zh active Active
- 2011-06-30 JP JP2012549653A patent/JP5903386B2/ja active Active
- 2011-06-30 KR KR1020137018996A patent/KR101836554B1/ko active IP Right Grant
- 2011-06-30 SG SG10201510576WA patent/SG10201510576WA/en unknown
- 2011-06-30 DK DK11850585.8T patent/DK2657234T3/da active
- 2011-06-30 SG SG2013048582A patent/SG191320A1/en unknown
- 2011-06-30 EP EP11850585.8A patent/EP2657234B1/en active Active
- 2011-06-30 RU RU2013133870/04A patent/RU2591701C2/ru active
- 2011-06-30 PL PL11850585T patent/PL2657234T3/pl unknown
- 2011-06-30 WO PCT/JP2011/065001 patent/WO2012086241A1/ja active Application Filing
-
2013
- 2013-06-20 IL IL227087A patent/IL227087A0/en active IP Right Grant
-
2015
- 2015-03-30 IL IL238032A patent/IL238032A/en active IP Right Grant
- 2015-11-04 HK HK15110896.7A patent/HK1210153A1/xx unknown
-
2016
- 2016-01-13 JP JP2016004539A patent/JP6364431B2/ja active Active
- 2016-02-03 IL IL243939A patent/IL243939A0/en active IP Right Grant
- 2016-02-22 IL IL244239A patent/IL244239B/en active IP Right Grant
- 2016-10-09 IL IL248246A patent/IL248246B/en active IP Right Grant
-
2017
- 2017-05-12 AU AU2017203187A patent/AU2017203187B2/en not_active Ceased
- 2017-08-15 JP JP2017156787A patent/JP2018009008A/ja active Pending
-
2019
- 2019-12-12 AR ARP190103632A patent/AR116907A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2657234T3 (da) | Optisk aktivt diazabicyclooctanderivat og fremgangsmåde til fremstilling heraf | |
DK3622883T3 (da) | Indførerer til medicinsk indretning og fremgangsmåder til at indføre og anvende medicinske indretninger | |
DK3260457T3 (da) | Fremgangsmåde til at fremstille carbamoylpyridonderivater og -mellemprodukter | |
DK3045187T3 (da) | Injektor og fremgangsmåde til samling | |
DK2857401T3 (da) | Hidtil ukendt -lactamaseinhibitor og fremgangsmåde til at fremstille samme | |
DK2675827T3 (da) | Hidtil ukendte modulatorer og fremgangsmåder til anvendelse | |
DK3468197T3 (da) | Fremgangsmåde til interforudsigelse og indretning dertil | |
DK3327040T3 (da) | Multimeriske opløselige il-15-fusionsmolekyler og fremgangsmåder til at fremstille og anvende samme | |
DK2602089T3 (da) | Resinform til nanotryk og fremgangsmåde til fremstilling deraf | |
DK2635337T3 (da) | Pakke med kateter og fremgangsmåde til sterilisering deraf | |
DK2632954T4 (da) | Midler og fremgangsmåder til behandling af dlbcl | |
DK3263100T3 (da) | L-ornithinphenylacetat og fremgangsmåder til fremstilling deraf | |
DK2408807T3 (da) | Fremgangsmåde til terapeutisk anvendelse | |
DK2758349T3 (da) | Vanadiumbaserede frittematerialer og fremgangsmåder til fremstilling heraf | |
DK3156075T3 (da) | Oligosaccharid og fremgangsmåde til fremstilling deraf | |
DK2584921T3 (da) | Sondeernæringspakninger og fremgangsmåder til anvendelse deraf | |
DK2596099T3 (da) | Fremgangsmåde til høst af ekspressionsprodukter | |
DK2771022T3 (da) | Cd40l-specifikke tn3-afledte skeletter (scaffolds) og fremgangsmåder til anvendelse deraf | |
DK2600715T3 (da) | Flydende ST-246-formuleringer og fremgangsmåder | |
NO345087B1 (no) | System og fremgangsmåte for forspenning av stigerør | |
BRPI1005433A2 (pt) | preparações farmacêuticas transdérmicas | |
DK2908661T3 (da) | Mikroalgemelgranulater og fremgangsmåde til fremstilling deraf | |
DK2544986T3 (da) | System og fremgangsmåde til aseptisk dosering | |
BR112013009579A2 (pt) | método e comprimido | |
DK2627656T3 (da) | Fremgangsmåde til fremstilling af dihydropteridinon og intermediater deraf |